Funding Rounds
Vaxxel

Vaxxel Seed (2022, $1M)

Vaxxel

Platform for intranasal vaccine candidates preventing pneumovirus infections.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $1.32M

Raised Date: 2022-01-01